Induced fit is a model explaining how enzymes change shape when they bind to the molecules they act on. Rather than being rigid structures waiting for a perfect match, enzymes are flexible. When the right molecule approaches, the enzyme’s active site reshapes itself to grip that molecule snugly, like a hand closing around a ball. Daniel Koshland proposed this idea in 1958, and it replaced the earlier view that enzymes worked like unchanging locks waiting for the right key.
How Induced Fit Differs From Lock and Key
The older model, proposed by Emil Fischer in the 1890s, treated enzymes as rigid structures. A substrate (the molecule an enzyme acts on) either fit perfectly into the active site or it didn’t, much like a key sliding into a lock. This explained some things well. If a molecule was too small or the wrong shape, it wouldn’t bind strongly enough to react. But the lock-and-key model couldn’t explain certain observations. For instance, researchers found that when a substrate binds to an enzyme, chemical groups that were previously buried inside the protein become exposed on its surface. A rigid enzyme can’t do that. Binding to a rigid structure can only bury groups, not reveal new ones.
Koshland’s induced fit theory kept Fischer’s core idea of complementarity (the enzyme and substrate do need to match) but added flexibility. He defined it in three parts: enzymes require precise alignment of their catalytic groups to work, the substrate causes a measurable change in the three-dimensional arrangement of amino acids at the active site, and only the correct substrate triggers the right rearrangement. A wrong molecule might bind loosely, but it won’t cause the shape change needed to activate the enzyme. He compared it to a hand sliding into a glove, where the glove (the enzyme) molds itself around the hand (the substrate).
What Happens During the Shape Change
When a substrate approaches an enzyme, the active site isn’t yet in its ideal catalytic shape. Contact with the substrate triggers a structural rearrangement: amino acid side chains shift position, loops of the protein backbone move, and sometimes entire sections of the enzyme rotate relative to each other. This continues until the substrate is seated in a configuration that positions the enzyme’s catalytic machinery precisely where it needs to be.
The classic example is hexokinase, an enzyme that attaches a phosphate group to glucose. X-ray crystallography revealed that when glucose enters the active site, one lobe of the hexokinase molecule rotates 12 degrees relative to the other lobe. Parts of the protein backbone shift by as much as 8 angstroms (less than a nanometer, but enormous at the molecular scale). The enzyme essentially closes a cleft around the glucose molecule, excluding water and creating the tight environment needed for the chemical reaction. Without glucose present, that cleft stays open.
Why Flexibility Matters for Specificity
At first glance, a flexible enzyme might seem less selective than a rigid one. The opposite is true. The conformational change acts as a molecular switch. When the correct substrate binds, it triggers the precise rearrangement that aligns the enzyme’s catalytic groups and stabilizes the transition state, the brief, high-energy arrangement of atoms where the chemical reaction actually happens. The enzyme proceeds to catalyze the reaction.
When an incorrect molecule binds, it either fails to trigger the conformational change at all or triggers an imprecise one. In that case, the catalytic groups don’t align properly, and the molecule tends to fall away from the active site before any reaction occurs. The wrong substrate dissociates quickly, favoring release over reaction. This gives induced fit a gatekeeping role: only molecules that produce the correct shape change get processed.
How Induced Fit Lowers the Energy Barrier
Enzymes speed up reactions by lowering the activation energy, the energy hill that molecules need to climb before a reaction can proceed. Induced fit contributes to this in two ways.
In the simpler scenario, the conformational change stabilizes the enzyme-substrate complex. The reshaped enzyme grips the substrate more tightly than a rigid enzyme would, which improves binding efficiency. The energy of the transition state drops by a similar amount, so the reaction rate for a given enzyme-substrate pair doesn’t change much, but the enzyme becomes better at capturing substrates from dilute solutions.
In the more powerful scenario, the shape change lowers the energy of the transition state more than it lowers the energy of the enzyme-substrate complex. This means the conformational rearrangement doesn’t just improve binding. It actively makes the chemical step faster by creating an environment around the substrate that preferentially stabilizes the transition state. The alignment of catalytic groups and the chemical surroundings the enzyme generates differ depending on which substrate is bound, which is why enzymes can be extraordinarily selective even among structurally similar molecules.
Induced Fit vs. Conformational Selection
Modern biochemistry recognizes that induced fit isn’t the only way enzymes can adapt. A competing framework called conformational selection, introduced by Monod, Wyman, and Changeux, proposes that enzymes naturally fluctuate between multiple shapes even before a substrate arrives. The substrate doesn’t force the enzyme into a new shape. Instead, it “selects” from pre-existing conformations, binding preferentially to the one that already fits.
The key question is whether the preferred shape of the enzyme in a bound complex is created by the substrate’s arrival or was already flickering in and out of existence beforehand. In practice, most enzymes probably use both mechanisms. Recent cryo-electron microscopy (cryo-EM) work on a DNA-processing enzyme called topoisomerase captured this directly: the enzyme first exists in multiple conformations, the substrate selects the closest matching one, and then additional induced fit adjustments occur after initial binding. In that study, binding of DNA caused specific structural elements to shift by 5.5 to 8.3 angstroms, repositioning a critical catalytic residue by 7.3 angstroms to bring it into contact with the DNA. The real picture, then, is often selection followed by induced fit rather than one or the other alone.
Applications in Drug Design
The induced fit concept has practical consequences for designing medicines. When pharmaceutical researchers use computers to predict how a drug candidate will bind to a protein target, they need to account for the fact that the protein won’t hold still. A drug molecule, like a substrate, can trigger conformational changes that reshape the binding pocket. If the simulation treats the protein as rigid, it may miss viable drug candidates or overestimate the fit of poor ones.
Modern computational methods combine multiple techniques to handle this. They start with an approximate docking of the drug molecule into the binding site, then run molecular dynamics simulations that let the protein flex and adjust in a virtual water environment. This approach has proven accurate enough to predict binding poses for challenging targets where simpler rigid-body docking fails, substantially expanding the range of proteins that computer-aided drug design can tackle.